This profile is a brief introduction for people seeking employment in pharmaceutical graduate jobs, pharmaceutical nurse advisors, pharmaceutical sales jobs, pharmaceutical training jobs, pharmaceutical sales management jobs, pharmaceutical marketing jobs, pharmaceutical executive jobs, or pharmaceutical clinical research associates who may be considering working for Astellas.

Company Overview

On 1 April 2005 Fujisawa and Yamanouchi officially merged to form Astellas Pharma Inc. The merger has created a company which ranks second in Japanese pharma market and around 17th overall in the global pharma market.

With ethical drugs as its core business, Astellas is a new force in the world pharmaceutical market. The Company has outstanding R&D and independent marketing ability which has a strong competitive edge in not only the domestic but also global markets. Astellas is committed to aggressively developing business and ensuring sustained increases in the corporate value as a "global pharmaceutical company originated in Japan" which contributes toward improving the health of people around the world through the provision of innovative and reliable pharmaceutical products.

Astellas is focused on three key therapy areas: urology, dermatology, and transplantation. These therapy areas are key to Astellas Europe and the organisation is committed to continuing to explore opportunities and to develop new products which will better serve patients affected by conditions across these areas.


Product Overview

Astellas Europe is primarily focused on three areas:

 - Urology- Vesicare, Flomax MR
- Dermatology- Protopic, Zineryt                       
- Transplantation